Table 23.
Level of Recommendation Concerning Combination Treatment during the Maintenance Phase
| Agent/modality | MS | Cbz | Lam | Li | Val |
|---|---|---|---|---|---|
| Quetiapine | 1 | - | - | - | - |
| Aripiprazole | 2 | - | 5 | - | 5 |
| RLAI | 2 | - | - | - | - |
| CBT | 2 | - | - | - | - |
| Phenytoin | 2 | - | - | - | - |
| Paroxetine | 3 | - | - | - | - |
| Psychoeducation | 3 | - | - | - | - |
| Olanzapine | 4 | - | - | - | - |
| Ziprasidone | 4 | - | - | - | - |
| N-acetyl cysteine | 4 | - | - | - | - |
| Imipramine | - | - | - | 5 | - |
| Memantine | 5 | - | - | - | - |
| Oxcarbazepine | - | - | - | 5 | - |
| Lithium | - | - | 4 | - | - |
| Perphenazine | 5 | - | - | - | - |
Abbreviations: CBT, cognitive behavioral therapy; Cbz, carbamazepine; Lam, lamotrigine; Li, lithium; MS, mood stabilizer; RLAI, Risperidone Long Acting Injection; Val, valproate.